DUALITAS THERAPEUTICS, INC.

Profile

Company Names

DUALITAS THERAPEUTICS, INC.

Addresses

681 GATEWAY BOULEVARD, SUITE 411, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(917) 640-1086

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2023

State Incorporated:

DELAWARE

Total Amount Raised:

$32,599,997.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2025-07-07 
$32,599,997.00 
$66,599,990.00 
$33,999,993.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FORBES 
 
HUANG 
EXECUTIVE OFFICER
DUALITAS THERAPEUTICS, INC.
THOMAS 
 
HUDSON 
DIRECTOR
TRIPHASE ACCELERATOR G.P. CORP   |  SYNERGY MED GLOBAL DESIGN SOLUTIONS LLC   |  MUNICIPAL PARKING SERVICES, INC.   |  NEW AGRARIAN CO LTD   |  DUALITAS THERAPEUTICS, INC.
GREG 
 
LAZAR 
EXECUTIVE OFFICER
DUALITAS THERAPEUTICS, INC.
ALICIA 
 
LEVEY 
DIRECTOR
DUALITAS THERAPEUTICS, INC.
MARK 
 
MCDADE 
DIRECTOR
FIVE PRIME THERAPEUTICS INC   |  DERMIRA, INC.   |  PLATELET BIOGENESIS, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  TALARIS THERAPEUTICS, INC.   |  WINDMIL THERAPEUTICS, INC.   |  BOULDER CARE, INC.   |  SODA HEALTH, INC.   |  DUALITAS THERAPEUTICS, INC.
RICHARD 
 
MURRAY 
EXECUTIVE OFFICER, DIRECTOR
VARIANCE ACRYLIC FINISHES, LLC   |  JOUNCE THERAPEUTICS, INC.   |  PLATELET BIOGENESIS, INC.   |  TELARUS PARENT HOLDINGS, INC.   |  BWO CORP.   |  DUALITAS THERAPEUTICS, INC.
MICHAEL 
 
ROSS 
DIRECTOR
CERVILENZ INC   |  JUVARIS BIO THERAPEUTICS INC   |  IKANO THERAPEUTICS INC.   |  ADIMAB, INC.   |  SV LIFE SCIENCES FUND V LP   |  LINK MEDICINE CORP   |  CATABASIS PHARMACEUTICALS INC   |  SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.   |  ARSANIS, INC.   |  BALANCE HEALTH CORP   |  ABCAM PLC   |  ADIMAB, LLC   |  AVITIDE, INC.   |  OPHTHOTECH CORP.   |  THESAN PHARMACEUTICALS, INC.   |  SV LIFE SCIENCES FUND VI, L.P.   |  DECIPHERA PHARMACEUTICALS, LLC   |  DEMENTIA DISCOVERY LP   |  AMERICLEAN HOLDINGS LLC   |  SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.   |  FRESCO FOODS, INC.   |  SUTRO BIOPHARMA INC   |  RIBOMETRIX, INC.   |  JASON RYAN   |  NICE RECOVERY SYSTEMS LLC   |  THERINI BIO, INC.   |  MAINE CRISP COMPANY, LLC   |  JOSEPH VENTURES ALLIUM I LLC, SERIES A   |  XILIO THERAPEUTICS, INC.   |  JOSEPH VENTURES ALLIUM I LLC, SERIES C   |  SV LIFE SCIENCES FUND IV CF, L.P.   |  ANDOVIA INC.   |  TREX HOLDINGS INC.   |  DUALITAS THERAPEUTICS, INC.
NIKOLA 
 
TRBOVIC 
DIRECTOR
ARRAKIS THERAPEUTICS, INC.   |  TREX HOLDINGS INC.   |  DUALITAS THERAPEUTICS, INC.
NEIL 
 
WEIR 
DIRECTOR
BERYLLIUM, LLC   |  DUALITAS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-07-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#